Top 10 TB (tuberculosis) journals

Approx.
5 min read
chest x-ray
Caption:
First Published: 
Feb 2022
Updated: 
Apr 2024

Key Learnings contained in this article:

Article Contents

  1. Introduction
  2. An overview of important Journal Metrics
  3. A list of the top ranked journals for this therapeutic area
  4. Ways to stay up to date with the latest research developments

Introduction

Even after nearly 150 years since the height of the tuberculosis (TB) epidemic in the US and Europe, the battle against this infectious disease continues. Caused by the bacterium Mycobacterium tuberculosis, TB predominantly affects the lungs and remains a significant global health challenge. In recent years, concerted efforts have led to progress, yet TB still causes substantial mortality, particularly among populations with HIV, malnutrition, or diabetes.

Marking World TB Day on March 24th, this update highlights the top TB journals for 2024. These publications are pivotal for medical professionals seeking to advance their understanding of TB prevention, diagnosis, and treatment, with the ultimate goal of eradicating TB worldwide.

How journal quality is measured

Here you will find the top 10 TB journals ranked by the 2-year Journal Impact Factor (2-JIF) – a measure of the frequency with which the articles within the journal are cited in a particular 2-year period.

We have also included the SJR, SNIP, and H-index for each journal in our assessment to round off the picture.

Impact factor

Impact factor is based on Web of Science data and only includes documents such as articles and reviews. It measures the average number of times an article is cited by other journal articles and documents. The JIF helps to understand the importance of how often articles are cited by addressing the bias that arises from comparing citation numbers which tends to favour bigger and older journals over smaller and newer ones.

By considering the impact factor, we can more fairly compare journals by taking into account these differences in size, publication frequency, and age. A JIF of 3 or more is considered good and 1 is average.

CiteScore

CiteScore is based on Scopus data for all indexed documents, including articles, letters and editorials. Like the impact factor, it measures the average citations received per document published in a journal over a 4-year time period.

  • Impact factor and CiteScore have the most meaning when used to compare journals within the same therapeutic area or subject. Many academics value a journal’s impact factor over its CiteScore; therefore they will use the impact factor to rank other journals in the same field.

SCImago Journal Rank (SJR)

SJR measures the citations received from a journal but it also considers the importance of the journal where the citations have come from. This measurement can be helpful to rank journals within the same field and category. An SJR >1.0 is above average.

Source Normalised Impact per Paper (SNIP)

Source Normalised Impact per Paper (SNIP) weights citations based on the total number of citations in a subject field to provide a contextual, subject-specific metric. A SNIP over 1.0 means a journal has more citations than average.

H-Index

H-Index is the number of papers published in a journal (h) that have been cited at least (h) times. For example, if a journal has published 50 papers and each of those papers have been cited by other authors at least 50 times, the H-index of the journal is 50. The higher the H-Index, the higher the quality of the journal.

Top 10 Tuberculosis (TB) Journals

Selecting the right journal for your research is a critical step that can make or break the impact of your work. This is where a medcomms agency like Rx Communications can become an essential ally. With a deep understanding of the scientific publishing world and high levels of therapeutic area expertise, a medcomms agency worth its salt should be able to provide support at any stage of the publishing process. This includes assisting in finding journals that match your research area and larger aims, and shaping your manuscript so it reflects the ethos and audience of your chosen journal, as well as guiding you through the entire submission process including managing revisions, and planning for post-publication promotion and dealing with rejection.

Rx can increase your chances of not just getting published, but also ensuring your research makes the waves it deserves.

The Lancet Respiratory Medicine

The Lancet Respiratory Medicine was launched in March 2013 as the fourth Lancet specialty journal. It is a global leader in critical care and respiratory medicine, delivering expert review, candid commentary, and breaking news.

  • Impact Factor: 76.2
  • CiteScore: 74.8
  • SJR: 11.204
  • SNIP: 10.810
  • H-Index: 159

European Respiratory Journal

The European Respiratory Journal is the leading peer-reviewed respiratory journal in Europe, publishing clinical and experimental work on all aspects of adult and pediatric respiratory medicine.

  • Impact Factor: 24.9
  • CiteScore: 25.3
  • SJR: 4.722
  • SNIP: 3.602
  • H-Index: 267

American Journal of Respiratory and Critical Care Medicine

The American Journal of Respiratory and Critical Care Medicine focuses on understanding the pathophysiology and treatment of respiratory system diseases and critically ill patients.

  • Impact Factor: 24.7
  • CiteScore: 28.7
  • SJR: 6.237
  • SNIP: 4.582
  • H-Index: 404

Respiratory Research

Respiratory Research is an open-access journal publishing high-quality clinical and basic research, reviews, and commentary on all aspects of respiratory medicine.

  • Impact Factor: 5.8
  • CiteScore: 9.5
  • SJR: 1.753
  • SNIP: 1.444
  • H-Index: 120

Respiratory Medicine

Respiratory Medicine publishes clinically relevant research on all aspects of respiratory diseases, from immunology to occupational disorders.

  • Impact Factor: 4.3
  • CiteScore: 7.0
  • SJR: 1.334
  • SNIP: 1.202
  • H-Index: 134

International Journal of Tuberculosis and Lung Disease

The International Journal of Tuberculosis and Lung Disease is the leading journal dedicated to lung health, covering clinical and community aspects of pneumology.

  • Impact Factor: 4.0
  • CiteScore: 4.1
  • SJR: 0.966
  • SNIP: 0.816
  • H-Index: 118

Tuberculosis

Tuberculosis focuses on basic experimental research, including the host response and immunology of tuberculosis, as well as the molecular biology of the organism.

  • Impact Factor: 3.2
  • CiteScore: 4.9
  • SJR: 0.710
  • SNIP: 0.894
  • H-Index: 94

Tuberculosis and Respiratory Diseases

Tuberculosis and Respiratory Diseases, the official journal of the Korean Academy of Tuberculosis and Respiratory Diseases, publishes research articles on the pathophysiology, diagnosis, and treatment of TB and other respiratory diseases.

  • Impact Factor: 2.9
  • CiteScore: 5.4
  • SJR: 0.689
  • SNIP: 0.949
  • H-Index: 31

Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

The Journal of Clinical Tuberculosis and Other Mycobacterial Diseases is an open-access journal providing clinically relevant articles on TB and mycobacterial infections.

  • Impact Factor: 2.0
  • CiteScore: 3.6
  • SJR: 0.602
  • SNIP: 0.755
  • H-Index: 17

Indian Journal of Tuberculosis

The Indian Journal of Tuberculosis publishes research on clinical, epidemiological, public health, and social aspects of tuberculosis and lung diseases.

  • Impact Factor: N/A
  • CiteScore: 2.6
  • SJR: 0.452
  • SNIP: 0.700
  • H-Index: 24

Publish or Perish - as true now as it ever was

In the high-stakes world of pharma and biotech, "Publish or Perish" isn't just a catchy phrase—it's the stark reality. For pharma companies and researchers, it's not enough to develop breakthroughs; the real challenge lies in getting those findings recognised in top journals. In this game, it's not just about playing your cards right; it's about having a seasoned player on your team. With Rx Communications in your corner, you’ll be giving yourself the best chance to make an impact with your research. Explore our Publications Support Services here.

How to Stay Up-to-Date with TB Research Developments

For pharma professionals and researchers working in the field of Tuberculosis, it is vital to stay abreast of the latest research advancements. To stay on top you might:

  • Consider subscribing to our newsletter and receive updates to our top journal lists as well as other relevant industry and therapeutic developments as they happen.
  • Register for an account with your selected journal to get direct access to new research as it's published.
  • Customise an RSS feed for your selected journals to also further streamline the process, delivering the latest papers and articles directly to your digital doorstep.
  • Setting up a Google alert with research keywords to capture relevant news and studies from across the web.
  • Lastly, don't underestimate the power of social media; by following the publishers and journals in the field, you'll tap into a community of shared knowledge and discourse.

Article originally written by Erin Harrison and published in 2022, updated by Beth Howe and the Rx Team for 2024!

We'll deliver straight to your inbox

We take your privacy very seriously and will never share your details with other parties.
You're subscribed! We'll send you a welcome email shortly, keep an eye out and if you don't find it perhaps check the (sometimes over-zealous) spam folder.
Oops! Something went wrong while submitting the form.
Beth Howe
Medical Writer
Bachelors in Biomedical Sciences, Bachelors in Biochemistry and Molecular Biology
Beth Howe is a passionate medical writer and member of the Australasian Medical Writers Association. With a degree from Victoria University of Wellington, she began her career during the COVID-19 pandemic, aiming to combat misinformation with factual scientific communication. Specialising in transforming complex research into accessible content, Beth's work spans from research manuscripts to informative health articles.
Share this post

Discover the Power of Communication with Rx

Embark on your medcomms journey with Rx today and experience the difference of working with a world-class medical communications agency.

Child playing in autumn leaves
Copyright Rx Communications Ltd